November 5, 2022

High‐dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes syndrome

Key Points

Key points are not available for this paper at this time.

Abstract

ClinicalTrials.gov Identifier: NCT04948138. Initial release 24 June 2021, first patient enrolled 1 July 2021. https://clinicaltrials.gov/ct2/show/NCT04948138.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

María Paz Guerrero‐Molina

Hospital Universitario 12 De Octubre

Montserrat Morales‐Conejo

Research Institute Hospital 12 de Octubre

Aitor Delmiro

Research Institute Hospital 12 de Octubre

Journals

European Journal of Neurology

Actions

Institutions

Hospital Universitario La Paz

Instituto Cajal

Centre for Biomedical Network Research on Rare Diseases

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

High‐dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke‐like episodes syndrome

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study